Employees: 6,500
Size QuidelOrtho (QDEL) is a United States Health Care company (Medical Specialties) with a market value of $657M, the 2499th largest of 3,085 United States companies the cockpit tracks. Shares closed at $9.57 on 18 Nov 2026.
Performance Over six months the shares fell 19.6%, against -9.3% for the median peer and -2.2% for the United States market (cap-weighted) — 8th lowest of 21 in its peer set.
Growth Revenue fell 4.6% over the last twelve months (peer median +17.0%); the operating margin is -2.4% (peer median 13.7%).
Valuation It trades at 10.7× forward earnings against a peer median of 27.9× (3rd cheapest of 17).
Capital Return on invested capital runs 7.2 points below its cost of capital (6.2% WACC).
Short interest Short interest is 21.1% of the free float (30 Oct 2026).
Next results Next results expected around 17 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $2.59B | $2.73B | $2.79B | $2.99B | $3.26B |
| Revenue growth | — | -2% | -7% | -8% | — |
| Gross profit | $959M | $1.08B | $1.09B | $1.28B | $1.80B |
| EBITDA | $399M | $494M | $502M | $704M | $1.26B |
| Net income | -$369M | -$1.13B | -$2.05B | -$10.1M | $549M |
| Free cash flow | -$118M | -$83.0M | -$112M | $70.9M | $744M |
| Capital expenditure | $126M | $188M | $195M | $209M | $141M |
| Total debt | $3.12B | $2.83B | $2.68B | $2.61B | $2.85B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | QDEL | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -32.6% | -1.9% | 2nd lowest of 21 |
| 6-month return | -19.6% | -9.3% | 8th lowest of 21 |
| Distance from 52-week high | -73.1% | -29.3% | lowest of 21 |
| Revenue growth (TTM) | -4.6% | +17.0% | 4th lowest of 21 |
| Operating margin | -2.4% | 13.7% | 3rd lowest of 21 |
| Forward P/E | 10.7× | 27.9× | 3rd cheapest of 17 |
| ROIC minus cost of capital | -7.2 pp | +4.1 pp | 3rd lowest of 21 |
| EV / EBITDA | 9.0× | 14.9× | 3rd cheapest of 10 |
| Net debt / EBITDA | 7.4× | -1.0× | most indebted of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| QuidelOrtho QDEL | United States | $657M | -20% | -5% | -2% | 10.7× | n/a | n/a |
| Synektik SNT.WA | Poland | $662M | +10% | +32% | 24% | 13.8× | 0.2% | +47.5% |
| Shanghai Kinetic Medical 300326.SZ | China | $662M | -10% | -28% | 17% | 26.0× | 6.6% | -1.9% |
| AK Medical 1789.HK | Hong Kong | $642M | -23% | +16% | 26% | 10.5× | -11.5% | +6.7% |
| Shenzhen Sunnypol Optoelectornics 002876.SZ | China | $680M | -9% | +29% | 5% | 39.0× | 10.1% | +14.2% |
| Beijing Chunlizhengda Medical Instruments 1858.HK | Hong Kong | $631M | -28% | -9% | 31% | 8.5× | -9.5% | +1.5% |
| SunMax Biotechnology 4728.TWO | Taiwan | $630M | 0% | +19% | 51% | n/a | -2.6% | +18.8% |
| Delcath Systems DCTH | United States | $685M | +75% | +38% | 5% | 358.9× | 33.4% | +120.2% |
| Livsmed 491000.KS | South Korea | $687M | -47% | +89% | -77% | n/a | n/a | n/a |
| Shenzhen Lifotronic Technology 688389.SS | China | $692M | -14% | +14% | 13% | 29.9× | 11.6% | +13.3% |
| Shanghai Sanyou Medical 688085.SS | China | $692M | -23% | +15% | 4% | 50.0× | 29.0% | +6.8% |
| Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZ | China | $697M | +148% | -14% | 3% | n/a | 31.8% | -0.6% |
| Shanghai INT Medical Instruments 1501.HK | Hong Kong | $700M | -25% | +35% | 21% | 15.9× | -3.3% | +23.5% |
| Japan Lifeline 7575.T | Japan | $703M | +34% | +6% | 19% | 14.5× | -9.5% | +2.9% |
| SWS Hemodialysis Care 688410.SS | China | $706M | -11% | +31% | 19% | 23.5× | 16.2% | +25.9% |
| Xvivo Perfusion XVIVO.ST | Sweden | $611M | -32% | +18% | 12% | 53.1× | 35.9% | +35.2% |
| Doctorglasses Chain 300622.SZ | China | $710M | -22% | +6% | 14% | 22.8× | -3.4% | +15.7% |
| Nanosonics NAN.AX | Australia | $599M | -4% | +3% | 7% | 98.6× | 35.3% | +6.7% |
| Medistim MEDI.OL | Norway | $599M | +32% | +19% | 29% | 31.8× | -1.2% | +14.5% |
| Sight Sciences SGHT | United States | $599M | +122% | +16% | -30% | n/a | n/a | n/a |
| Caina Technology 301122.SZ | China | $721M | +36% | +61% | 0% | 55.4× | n/a | n/a |